Pure Biologics SA
XMUN:PQB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pure Biologics SA
XMUN:PQB
|
PL |
|
S
|
Shin Heung Energy & Electronics Co Ltd
KOSDAQ:243840
|
KR |
|
I
|
Immsi SpA
F:IMY
|
IT |
|
HIVE Digital Technologies Ltd
TSX:HIVE
|
CA |
|
R
|
Rabbit Holdings PCL
SET:RABBIT
|
TH |
|
Jasa Armada Indonesia Tbk PT
IDX:IPCM
|
ID |
|
Chariot Ltd
LSE:CHAR
|
GG |
|
Kenadyr Mining Corp
XTSX:KEN
|
CA |
|
Mission Bancorp
OTC:MSBC
|
US |
|
I
|
Indos SA
WSE:INS
|
PL |
|
M
|
Mostostal Warszawa SA
WSE:MSW
|
PL |
|
C
|
Comeco SA
WSE:CMC
|
PL |
|
LBT Innovations Ltd
ASX:CC5
|
AU |
|
A
|
Alpha Astika Akinita SA
ATHEX:ASTAK
|
GR |
|
T
|
Tyranna Resources Ltd
ASX:TYX
|
AU |
Bankruptcy Probability
Pure Biologics SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pure Biologics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PL |
P
|
Pure Biologics SA
WSE:PUR
|
661.4m PLN |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pure Biologics SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pure Biologics SA has total debt of 14.4m PLN. This includes both short-term (14.4m PLN) and long-term (0 PLN) debt.
You can find a full breakdown on its Balance Sheet.
